In prostate cancer and pancreatic cancer, P4HA1 increased both on mRNA and protein levels, and P4HA1 expression was correlated with poor overall survival in pancreatic ductal adenocarcinoma patients 7, 11. This evidence concerns the gene P4HA1 and familial pancreatic carcinoma.